Author: admin

First-of-its-kind Dual-Drug Therapy for Coronary De Novo Disease Moves Toward U.S. Clinical Phase Novel Nanoparticle Technology Platform Aims to Deliver Two Proven Drugs for Vessel Patency and Restenosis Prevention SANTA CLARA, Calif., Oct. 26, 2024 /PRNewswire/ — Advanced NanoTherapies (ANT),

Magazine made for you.

Featured:

No posts were found for provided query parameters.

Elsewhere: